Tag: Supply chain
What to Consider when Scaling Fill/Finish for Cell & Gene Therapy?
Transitioning from lab manufacture to commercialization presents significant challenges, no matter what area you’re working in. Cell and gene therapies are no different and production quantities must scale at multiple stages, first to support clinical trials and then when they reach the market.
Benefitting from the Worldwide Supply Chain in the development of Antibody-drug...
Timing is everything.
Just over a decade ago, the pharmaceutical industry and R&D in China was dominated by generics and plagued with insufficient technical capacity...
Piramal Aims to Become the Global Leader in Antibody-drug Conjugates Development...
Over the past decades novel drugs for the treatment of human disease have become more complex. According to the Global Business Reports and CPhI joint Industry Explorations...
CPhI Worldwide 2015, Antibody-drug Conjugates and Market Progression
Ahead of CPhI Worldwide 2015, CPhI expert panelist, Vivek Sharma, CEO of Pharma Solutions at Piramal, analyses the challenges in developing and manufacturing of...
